ERK1/2 Inhibition Suppresses Allo-Reactive T cells, Leading to GVHD Inhibition

Key Points

• Inhibition of Erk1/2 leads to a significant reduction in allo-reactive T cells, mitigating GVHD.
• The study reported a notable decrease in GVHD incidence when Erk1/2 was inhibited.
• Experimental analysis across multiple models confirmed the effects of Erk1/2 inhibition on T cell activation.
• This highlights the potential of targeting Erk1/2 pathways in developing new GVHD treatment strategies.